Boehringer Ingelheim
Brianna Goldenstein possesses extensive experience in the fields of medical science and research, having served as Associate Director for Medical Science Liaison roles at Boehringer Ingelheim, focusing on Central Nervous System (CNS) and Idiopathic Pulmonary Fibrosis/Interstitial Lung Disease (IPF/ILD) from July 2017 to March 2021. Prior to this, Brianna was a Postdoctoral Research Fellow at CHUM - Centre hospitalier de l'Université de Montréal, conducting research on epilepsy and the adrenergic receptor system, while also mentoring students and co-authoring scientific publications. Earlier research experience includes a Graduate Research Assistant position at the University of North Dakota, where Brianna studied various aspects of the adrenergic receptor system and mentored numerous undergraduate students, along with roles as a Lab Technician and Undergraduate Research Assistant focused on epilepsy. Educationally, Brianna holds a Ph.D. in Pharmacology, Physiology, & Therapeutics (Neuroscience) and a B.S. in Biology from the University of North Dakota.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.